沙美特罗替卡松粉吸入剂对慢性阻塞性肺疾病稳定期的临床治疗效果.docVIP

沙美特罗替卡松粉吸入剂对慢性阻塞性肺疾病稳定期的临床治疗效果 　　【摘要】 目的：观察分析沙美特罗替卡松粉吸入剂（舒利迭）对慢性阻塞性肺疾病稳定期的临床治疗效果。方法：选取2012年 　　9月-2014年9月收治的72例慢性阻塞性肺疾病稳定期患者作为本组研究对象，根据患者入院尾号的奇偶数对其分为观察组与对照组各36例，给予对照组患者常规疗法，给予观察组患者常规疗法联合舒利迭治疗，治疗后，对比两组患者的肺功能改善情况、治疗总有效率以及不良反应等指标。结果：观察组患者的FEV1、FEV1/FVC、FEV1/预计值以及临床治疗总有效率等指标均优于对照组（P0.05）。结论：常规疗法的基础上联用舒利迭治疗稳定期慢性阻塞性肺疾病，能够有效改善患者肺功能，提高治疗效果。 　　【关键词】 舒利迭； 慢性阻塞性肺疾病； 稳定期； 肺功能 　　中图分类号 R563.5 文献标识码 B 文章编号 1674-6805（2015）33-0040-03 　　Analysis of Clinical Effect of Seretide in the Treatment of Stable Chronic Obstructive Pulmonary Disease/PU Zhuang-nan.//Chinese and Foreign Medical Research，2015，13（33）：40-42 　　【Abstract】 Objective：To observe the clinical curative effect of Seretide in the treatment stable chronic obstructive pulmonary disease.Method： 72 cases of stable period of chronic obstructive pulmonary disease patients in our hospital from September 2012 to September 2004 were selected，according to the patients admitted to hospital number mantissa which were even or odd points，they were divided into the observation group and the control group，36 cases in each group.The control group received conventional therapy，the observation group were treated with conventional therapy combined with Seretide treatment， lung function improvement，the total efficiency of the treatment and adverse reactions after treatment in two groups were compared.Result：The FEV1，FEV1/FVC，FEV1/Estimates and the total effect of the observation group were better than those of the control group（P0.05）.Conclusion：Conventional therapy combined with Seretide in the treatment of stable chronic obstructive pulmonary disease can effectively improve the patient’s lung function and improve the curative effect. 　　【Key words】 Sulidie； Chronic obstructive pulmonary disease； Stable stage； Pulmonary function 　　First-author’s address：Luzhi People’s Hospital of Wuzhong District in Suzhou City，Suzhou 215127，China 　　doi：10.14033/j.cnki.cfmr.2015.33.018 　　慢性阻塞性肺疾病（COPD）是一种常见的以持续气流受限为特征的可以预防和治疗的疾病，气流受限进行性发展，与气道和肺对有毒颗